Clinical Trials Browser

Thyroid Neoplasms

NCT07394062 2026-02-06

ALCG-01

Recruiting

400 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06599619 2026-01-26

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

Recruiting

30 enrolled

Dermatologic

Dysplastic Nevus Syndrome, Melanoma, Hereditary Sensory and Autonomic Neuropathies

NCT05287464 2025-11-26

International Multicentric Study ARON-1

Recruiting

1,220 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT07223411 2025-11-26

Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma

Recruiting

20 enrolled

Dermatologic

Locally Advanced Melanoma

NCT07092670 2025-09-05

MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.

Recruiting

270 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT06504615 2024-12-13

METAGIO

Recruiting

500 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Adenocarcinoma

NCT06693440 2024-11-18

The Immune Assessment of PD-1 Antibody Therapy in Tumor

Recruiting

3,000 enrolled

Efficacy, Team

NCT06627595 2024-11-15

APiTOXMM

Recruiting

160 enrolled

Dermatologic

Melanoma, Motor Activity

NCT06532149 2024-08-09

EROS

Recruiting

80 enrolled

OtherThoracic

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

Clinical Trials

NeoLATC

ALCG-01

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

International Multicentric Study ARON-1

Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma

MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.

METAGIO

The Immune Assessment of PD-1 Antibody Therapy in Tumor

APiTOXMM

EROS